Skip to content
Wenlo
Sign in
← Markets

BridgeBio Pharma Inc.

BridgeBio Pharma Inc. (BBIO) — Form 144: Proposed sale of shares

144BBIOFiled Nov 19, 2026, 11:21 AM ET

About this filing

BridgeBio Pharma Inc. (BBIO) filed Form 144 (proposed sale of shares) with the SEC on Nov 19, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More BBIO filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.